Literature DB >> 17311921

Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles.

Yue Zhang1, Qing Deng, Joseph T Barbieri.   

Abstract

ExoS (453 amino acids) is a bi-functional type III cytotoxin produced by Pseudomonas aeruginosa. Residues 96-219 include the Rho GTPase-activating protein (RhoGAP) domain, and residues 234-453 include the 14-3-3-dependent ADP-ribosyltransferase domain. Earlier studies also identified an N-terminal domain (termed the membrane localization domain) that comprises residues 51-77 and includes a novel leucine-rich motif that targets ExoS to the perinuclear region of cultured cells. There is limited information on how ExoS or other type III cytotoxins enter and target intracellular host proteins. Type III-delivered ExoS localized to both plasma membrane and perinuclear region, whereas ExoS(DeltaMLD) was localized to the cytosol. Plasma membrane localization of ExoS was transient and had a half-life of approximately 20 min. Type III-delivered ExoS co-immunoprecipitated 14-3-3 proteins and Rab9, Rab6, and Rab5. Immunofluorescence experiments showed that ExoS colocalized with Rab9, Rab6, and Rab5. Fluorescent energy transfer was detected between ExoS and 14-3-3 proteins but not between ExoS and Rabs proteins. Together, these results indicate that type III-delivered ExoS localizes on the host endosomes and utilizes multiple pathways to traffic from the plasma membrane to the perinuclear region of intoxicated host cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17311921     DOI: 10.1074/jbc.M606305200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function.

Authors:  Grace Soong; Dane Parker; Mariah Magargee; Alice S Prince
Journal:  J Bacteriol       Date:  2007-12-28       Impact factor: 3.490

2.  Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25.

Authors:  Sheng Chen; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

3.  TPD52 expression increases neutral lipid storage within cultured cells.

Authors:  Alvin Kamili; Nuruliza Roslan; Sarah Frost; Laurence C Cantrill; Dongwei Wang; Austin Della-Franca; Robert K Bright; Guy E Groblewski; Beate K Straub; Andrew J Hoy; Yuyan Chen; Jennifer A Byrne
Journal:  J Cell Sci       Date:  2015-07-16       Impact factor: 5.285

4.  Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.

Authors:  Hamideh Shahheydari; Sarah Frost; Brian J Smith; Guy E Groblewski; Yuyan Chen; Jennifer A Byrne
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

5.  The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells.

Authors:  Annette A Angus; David J Evans; Joseph T Barbieri; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

6.  Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells.

Authors:  Dacie R Bridge; Karen H Martin; Elizabeth R Moore; Wendy M Lee; James A Carroll; Claudia L Rocha; Joan C Olson
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

7.  Translocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS.

Authors:  Victoria Hritonenko; David J Evans; Suzanne M J Fleiszig
Journal:  Microbes Infect       Date:  2012-08-30       Impact factor: 2.700

8.  Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking.

Authors:  Nathan C Simon; Joseph T Barbieri
Journal:  Infect Immun       Date:  2013-10-07       Impact factor: 3.441

9.  The membrane localization domain is required for intracellular localization and autoregulation of YopE in Yersinia pseudotuberculosis.

Authors:  Elin L Isaksson; Margareta Aili; Anna Fahlgren; Sara E Carlsson; Roland Rosqvist; Hans Wolf-Watz
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

Review 10.  The type III secretion system of Pseudomonas aeruginosa: infection by injection.

Authors:  Alan R Hauser
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.